Improved antitumor efficacy of paclitaxel with nano-formulation in breast cancer
Breast cancer has been brought to the forefront of scientific research because of its increasing incidence as well as the growing demands to prolong the life span of patients and improve their quality of life. Paclitaxel (PTX), a small-molecule cytotoxic agent, is one of the most effective anti-canc...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2017-06-01
|
| Series: | Nanotechnology Reviews |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/ntrev-2016-0059 |